VLP is a biotech company with a mission to address unmet medical needs worldwide and expand the frontiers of vaccine treatment.
VLP Therapeutics has raised $21.0M in total funding. The most recent round was Series A. The last funding was announced in December 2021.
VLP Therapeutics's investors include MUFG Bank, Pegasus Tech Ventures, Miyako Capital, Global Health Innovative Technology Fund, Sojitz.
VLP Therapeutics is headquartered in Gaithersburg, United States.
VLP is a biotech company with a mission to address unmet medical needs worldwide and expand the frontiers of vaccine treatment.
VLP Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"VLP Therapeutics — Funding & Investors." VCBacked, December 27, 2021, https://www.vcbacked.co/company/vlp-therapeutics. Accessed November 13, 2026.
VCBacked. (2021). VLP Therapeutics — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/vlp-therapeutics
{{cite web |title=VLP Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/vlp-therapeutics |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at VLP Therapeutics? Request a listing update